Metformin Plus Insulin Therapy Does Not Reduce Neonatal Adve

Metformin Plus Insulin Therapy Does Not Reduce Neonatal Adverse Outcomes

Metformin plus insulin therapy vs placebo was not associated with reduced neonatal adverse outcomes among type 2 and gestational diabetes patients.

Related Keywords

United States , American , , Journal Of The American Medical Association , American Medical , Medical Optimization , Overt Type ,

© 2025 Vimarsana